Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
HER2-Targeted Therapy for Early-Stage Breast Cancer: A Comprehensive Review
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial - The Lancet
Dose-dense chemotherapy for breast cancer: what does the future hold? | Future Oncology
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer
Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 ...
Update on systemic treatment for newly diagnosed inflammatory breast cancer - ScienceDirect
Optimizing Adjuvant Chemotherapy in Early-Stage Breast Cancer
Dose-dense chemotherapy for breast cancer: what does the future hold? | Future Oncology
Frontiers | Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Pocket Guide to Chemotherapy Protocols: 9781449646813: Medicine & Health Science Books @ Amazon.com
Chemotherapy Protocol
SWOG S 0800 ( NCI CDR 0000636131 ) : addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response ( pCR ) rates in inflammatory or locally
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Current Oncology | Free Full-Text | Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy | SpringerLink
4102-Breast adjuvant/neoadjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) dose dense | eviQ
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen Content | JCO Clinical Cancer Informatics
